faculty portrait if available
Jill Comeau
Associate Professor
School of Clinical Sciences
PHSV 1010
318-342-1814
ULM logo

Jill M Comeau, PharmD
Associate Professor, School of Clinical Sciences- Shreveport Campus

Education

PharmD

2008, Pharmacy
Massachusetts College of Pharmacy Boston

faculty feature photo

Biographical Sketch

I am a board certified oncology pharmacist and currently practice as gratis assistant professor at the LSU-Health School of Medicine.  My practice site is located at the Feist-Weiller Cancer Center in Shreveport which serves patients from Shreveport to Monroe, East Texas, and as far south as Lake Charles.  We treat an indigent patient population with cancer according to evidence-based medicine as well as taking into account their social and economic struggles.

The clinics I am involved in include: breast, brain and sarcoma clinic, lung and head and neck clinic, digestive clinic, and benign and malignant hematology clinic.  My role is multifaceted and involves collaboration with hematology/oncology physicians and nurses to provide optimal patient care.  One of my main activities includes developing supportive care plans for cancer patients including but not limited to preventing and treating nausea and vomiting, pain, constipation, infections, etc.  I also counsel patients on oral cancer therapy, supportive care medications as well as verify home medications and herbal products to account for adherence as well as interactions with current cancer treatment.  I provide medication-based information to physicians as well as perform pharmacy informatics duties.

My main research areas of interest include retrospective reviews and patient education.  It has focused on efficacy, toxicity, and drug interactions with cancer treatments in patients with hematologic malignancies.  I am also expanding into research involving pharmacy-based medication education.  I am also interested in academic research regarding the role of pharmacy students in oncology practice.

Licensure & Certification

ASHP Pharmacogenomics Certificate, ASHP. (May 18 2022 - Present)
Oncology Genomics Certificate, American College of Clinical Pharmacy. (May 17 2021 - Present)
Medication Therapy Management Certificate Training Program, APhA. (July 2016 - Present)
Advanced Cardiac Life Support, American Heart Association. (May 2009 - Present)
Basic Life Support, American Heart Association. (January 14 2009 - Present)
Board Certified Oncology Pharmacist, BCOP, Board of Pharmacy Specialist. (December 1 2011 - December 31 2025)
Pharmacist, Louisiana Board of Pharmacy. (August 11 2010 - December 31 2024)
Pharmacist, Massachusetts Board of Pharmacy. (March 11 2009 - December 31 2024)
Pharmacist, Pennsylvania Board of Pharmacy. (August 18 2008 - September 30 2024)
Pharmacist, Georgia Board of Pharmacy. (June 9 2009 - December 31 2012)
Pharmacy Teaching Certificate, Mercer College of Pharmacy and Health Sciences. (August 1 2009 - June 4 2010)

Research Interests

  • Hematology/Oncology Patient Outcomes
  • Medication Adherence
  • Patient Education
  • Pharmacy Students Role in Oncology Services

Recent Publications

Hosseini, R., Comeau, J., Lerner, J., Gaddam, S. J., Shi, R., Beedupalli, K. Effects of antibiotic use on metastatic cancer patients receiving immunotherapy. Journal of Oncology Pharmacy Practice.
Comeau, J. M., Grosshart, E. Managing alectinib dosing in a patient diagnosed with metastatic non-small cell lung cancer receiving hemodialysis. ASHP Annual Meeting Professional Poster.
Comeau, J., Fancher, K. Chronic Leukemia. New York, NY: Pharmacotherapy: A Pathophysiologic Approach, DiPiro, McGraw-Hill Education, 13ed.
Thurlapati, A., Dhaliwal, L., Chennapraga, S., Gupta, P., Ralla, D., Comeau, J., Shi, R., Beedupalli, K. Effect of durvalumab in unresectable stage 3 non-small cell lung cancer patients post chemoradiotherapy. JCO Precision Oncology.
Comeau, J., Jois, S., Beedupalli, K. (2022). Multiple primary lung cancer tumours with diversified genetic mutations-complications in choosing therapeutic options. Clinical and Translational Discovery.
Thurlapati, A., Dhaliwal, L., Chennapragada, S., Gutta, P., Song, D., Ralla, D., Comeau, J., Beedupalli, K., Shi, R. Effect of durvalumab in unresectable stage 3 non-small cell lung cancer patients post chemoradiotherapy [abstract]. JCO.
Fancher, K., Comeau, J. M. (2023). Chronic Leukemia. New York, NY: Pharmacotherapy: A Pathophysiologic Approach, DiPiro, McGraw-Hill Education.
Hardin, M., Comeau, J. Multi-Faceted Review of Sub-Optimal Outcomes Concerning Breast Cancer Survivorship In African-American Women. Women & Health.
Corcoran, C., Comeau, J., Vutukuri, N. M., Stephenson, E., Shi, R., Beedupalli, K. (2021). Effect of Influenza Vaccination on Immune-Related Adverse Events in Patients Receiving Single-Agent Immune Checkpoint Inhibitors for the Treatment of Cancer. Journal of Clinical Oncology.
Jois, S., Palleria, S., Abdul, A. u., Comeau, J. (2021). Cancer Vaccines, Treatment of the Future: With Emphasis on HER2-Positive Breast Cancer (pp. 779). International Journal of Molecular Sciences.
(2020). Rectal Cancer. Pharmacotherapy First.
(2019). Effect of acid-reducing agents on the efficacy of capecitabine in metastatic gastrointestinal cancers. (pp. e15058). Journal of Clinical Oncology.
(2019). Use of Hydroxyurea in adult patients diagnosed with Sickle cell disease. (pp. 1-3). Louisiana Medicaid Provider Update.
(2017). Pharmacist's application to practice, Niraparib (Zujula) for maintenance therapy in patients with platinum-sensitive recurrent epithelial ovarian cancer, fallopian tube, or primary peritoneal malignancy. Drug Updates. HOPA.
(2017). Hematology Oncology Pharmacy Association (HOPA) entry-level competencies task force response statement to the 2016 American College of Clinical Pharmacy (ACCP) pharmacotherapy didactic curriculum toolkit. (pp. e30-31). Pharmacotherapy.
Comeau, J. M., Jean, G., Kelly, K. (2018). Elotuzumab in the Treatment of Relapsed or Refractory Multiple Myeloma. Bethesda, MD: AJHP.
Comeau, J. M., Wehr, T., Peyton-Thomas, B. (2016). Efficacy and Cost Analysis of a Plerixafor Protocol for Peripheral Blood Stem Cell Mobilization in Patients Diagnosed with Multiple Myeloma and non-Hodgkin's Lymphoma. Baltimore, MD: JHOP.
Comeau, J. M. (2015). The role of obinutuzumab in the treatment of chronic lymphocytic leukemia (pp. 933-42). Bethesda, MD: American Journal of Health-System Pharmacy.
Comeau, J. M. (2014). Impact of race and payer status on the outcome of chronic myeloid leukemia in the era of tyrosine kinase inhibitors. (pp. e17568). Alexandria, VA: Journal of Clinical Oncology/American Society of Clinical Oncology.
Comeau, J. M. Preventing Toxicities in Patients Receiving Endocrine Therapy for Breast Cancer. Baton Rouge: Louisiana Medicaid Provider Update.
Comeau, J. (2013). Ponatinib: a new tyrosine kinase inhibitor for the treamtnet of chronic myeloid leukemia and Philadelphia chromosome-postiive acute lymphoblastic leukemia (pp. 1540-1546). Cincinnati, OH: The Annals of Pharmacotherapy/SAGE Publications.
Comeau, J. (2013). The BMT Data Book, The BMT/SCT Pharmacopoeia, 3rd edition (pp. 816-1028). Cambridge: Cambridge University Press.
Comeau, J., Labruzzo Mohundro, B. A. (2013). From Bench to Bedside, Promising Colon Cancer Clinical Trials. Plainsboro, NJ: The American Journal Of Managed Care Evidence-Based Oncology.
Comeau, J., Labruzzo Mohundro, B. A. (2012). Lung Cancer Pipeline. Plainsboro, NJ: The American Journal Of Managed Care Evidence-Based Oncology.
Comeau, J. (2012). Successful treatment of first and second recurrence of acute lymphoblastic leukemia after related allogeneic bone marrow transplant at unusual sites using single-dose vincristine followed by interferon-alpha 2b and GMCSF (pp. 1-3). London: Leukemia Lymphoma.
Comeau, J. Successful treatment of first and second recurrence of Acute Lymphoblastic Leukemia after related allogeneic bone marrow transplantation at unusual sites using single dose vincristine followed by Interferon-alpha 2b and GM-CSF (pp. 3). London, Informa Healthcare: Leukemia and Lymphoma.
Comeau, J. (2012). Pharmacologic Prevention and Treatment of Sickle Cell Pain Crisis in Adults (pp. 6-7). Baton Rouge, LA: Louisiana Medicaid Provider Update.
Comeau, J. (2011). Rapid remission induction through cytokine modulation in a patient with early relapse of acute lymphoblastic leukemia at unusual site after alllogeneic stem cell transplantation. Alexandria, VA: Journal of Clinical Oncology.
Comeau, J. Characteristics and long term outcomes of diabetic breast cancer patients treated with paclitaxel. San Antonio, TX: San Antonio Breast Cancer Symposium.
Comeau, J. (2011). Romiplostin for the treatment of amegakaryocytic thrombocytopenia secondary to remission-inducing immunomodulation in a patient with relapsing Acute Lymphoblastic Leukemia after allogeneic HSCT (pp. abstract 6609). Alexandria, VA: ASCO/Journal of Clinical Oncology/2011 Annual Meeting Abstracts.
Comeau, J. (2008). . Excessive anticoagulation and bleeding events; a case presentation. Roxbury, MA: eThrombosis, North American Thrombosis Forum.

Research Grants

, "Evaluation of the adherence of tamoxifen compared to goserelin and aromatase inhibitors in the treatment of premenoupausal women with breast cancer enrolled in Louisiana Medicaid" (), Sponsored By ULM COP Faculty Research Support Award, The University of Louisiana at Monroe, $3,880.00. (March 1 2019 - Present).
Comeau, J. M. (Principal), Perry, E. C. (Co-Principal), Storer, A. (Co-Principal), Lafitte, E. M. (Co-Principal), "Computer-based Clinical Simulation for Health and Pharmaceutical Sciences" (Not Funded), Sponsored By ULM, The University of Louisiana at Monroe, $7880. (June 1 2015 - June 2015).

Awards & Honors

May 2024 Class of 2025 Team Taught Class of the Year.

May 2023 Class of 2024 Team Taught Class of the Year.

May 2023 Class of 2024 Excellence in Teaching Award.

August 2022 Dean's Award for Excellence in Clinical Care.

May 2022 Class of 2023 Excellence in Teaching Award.

2021 Warhawk Lightning Talks Scholar Faculty Works in Progress.

January 2012 Gratis Asistant Professor of Medicine in the Feist Weiller Cancer Center and the Bone Marrow transplant unit of the LSUHSC-Shreveport.

Courses Taught

PHAR 5088Disease Pathogen & Pharm Iv, 1 course(s)

PHRD 4079SELF CARE/PATIENT ASSESS I MOD, 3 course(s)

PHRD 5004ADVANCED COMMUNICATION, 7 course(s)

PHRD 5022THERAPEUTICS VI, 3 course(s)

PHRD 5035HEMATOLOGY/ONCOLOGY MODULE, 7 course(s)

PHRD 5047THERAPEUTICS VIII, 6 course(s)

PHRD 5049INTEGRATED LAB SEQUENCE VI, 9 course(s)

PHRD 5051AGING DRUG USE IN ELDERLY, 7 course(s)

PHRD 5054HOSPITAL ADMINISTRATION, 6 course(s)

PHRD 5061WOMEN'S HEALTH AND PHARMACIST, 9 course(s)

PHRD 5065CLINICAL PHARMACY CAREER DEV, 6 course(s)

PHRD 5067PROBLEMS WITH THERAPEUTICS, 1 course(s)

PHRD 6004ADV AMBULATORY CARE PHAR PRACT, 8 course(s)

PHRD 6008ADV SPECIALTY PHAR PRACT EX, 4 course(s)

PHRD 6010ADV PHAR PRACT ELECTIVE EX, 7 course(s)